Amy J. Ramsey

1 King's College Circle
Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

Gene Portals: A Framework for Integrating Clinical, Functional, and Structural Evidence into Rare Disease Variant Classification.

Gene Portals: A Framework for Integrating Clinical, Functional, and Structural Evidence into Rare Disease Variant Classification.

Journal: medRxiv : the preprint server for health sciences

Published: March 13, 2026

Gene Portals: A Framework for Integrating Clinical, Functional, and Structural Evidence into Rare Disease Variant Classification.

Gene Portals: A Framework for Integrating Clinical, Functional, and Structural Evidence into Rare Disease Variant Classification.

Journal: medRxiv : the preprint server for health sciences

Published: March 13, 2026

Neurodevelopmental disorder-causing GRIN1 Y647S variant alters red blood cell physiology in mice.

Neurodevelopmental disorder-causing GRIN1 Y647S variant alters red blood cell physiology in mice.

Journal: Physiological reports

Published: September 23, 2025

Context-dependent NMDA receptor dysfunction predicts seizure treatment in mice with human GluN1 variant.

Context-dependent NMDA receptor dysfunction predicts seizure treatment in mice with human GluN1 variant.

Journal: iScience

Published: May 14, 2025

Alpha-methyl-para-tyrosine and amphetamine ameliorate hyperactivity in a novel mouse model of dopamine transporter deficiency syndrome.

Alpha-methyl-para-tyrosine and amphetamine ameliorate hyperactivity in a novel mouse model of dopamine transporter deficiency syndrome.

Journal: EMBO molecular medicine

Published: April 03, 2025

Non-Ionotropic NMDA Receptor Signaling in Mechanistically Distinct Forms of Hippocampal Depotentiation.

Non-Ionotropic NMDA Receptor Signaling in Mechanistically Distinct Forms of Hippocampal Depotentiation.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience

Published: February 21, 2025

Grin1 Y 647 S/+ Mice: A Preclinical Model of GRIN1 -Related Neurodevelopmental Disorder.

Grin1 Y 647 S/+ Mice: A Preclinical Model of GRIN1 -Related Neurodevelopmental Disorder.

Journal: bioRxiv : the preprint server for biology

Published: September 04, 2024

Combination of Haloperidol With UNC9994, β-arrestin-Biased Analog of Aripiprazole, Ameliorates Schizophrenia-Related Phenotypes Induced by NMDAR Deficit in Mice.

Combination of Haloperidol With UNC9994, β-arrestin-Biased Analog of Aripiprazole, Ameliorates Schizophrenia-Related Phenotypes Induced by NMDAR Deficit in Mice.

Journal: The international journal of neuropsychopharmacology

Published: April 25, 2024

Nanobody therapy rescues behavioural deficits of NMDA receptor hypofunction.

Nanobody therapy rescues behavioural deficits of NMDA receptor hypofunction.

Journal: Nature

Published: November 09, 2023

Tricyclic and tetracyclic antidepressants upregulate VMAT2 activity and rescue disease-causing VMAT2 variants.

Tricyclic and tetracyclic antidepressants upregulate VMAT2 activity and rescue disease-causing VMAT2 variants.

Journal: bioRxiv : the preprint server for biology

Published: October 24, 2023

Tricyclic and tetracyclic antidepressants upregulate VMAT2 activity and rescue disease-causing VMAT2 variants.

Tricyclic and tetracyclic antidepressants upregulate VMAT2 activity and rescue disease-causing VMAT2 variants.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Published: October 09, 2023

Deficits in integrative NMDA receptors caused by Grin1 disruption can be rescued in adulthood.

Deficits in integrative NMDA receptors caused by Grin1 disruption can be rescued in adulthood.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Published: November 22, 2022

Showing 1-12 of 51

Last Updated: 09/26/2026